Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology
For Type I diabetics, the New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs
